Financial results - FARMACIA NR.30 SRL

Financial Summary - Farmacia Nr.30 Srl
Unique identification code: 7645454
Registration number: J36/420/1995
Nace: 7500
Sales - Ron
38.912
Net Profit - Ron
3.769
Employee
1
The most important financial indicators for the company Farmacia Nr.30 Srl - Unique Identification Number 7645454: sales in 2023 was 38.912 euro, registering a net profit of 3.769 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activităţi veterinare having the NACE code 7500.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Farmacia Nr.30 Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 60.685 70.173 58.319 54.982 58.336 49.825 55.123 40.645 45.532 38.912
Total Income - EUR 60.685 70.173 58.319 54.982 58.336 49.825 55.211 40.645 45.534 38.912
Total Expenses - EUR 58.084 66.088 60.269 57.605 60.071 64.335 50.533 38.597 41.038 34.397
Gross Profit/Loss - EUR 2.601 4.085 -1.950 -2.623 -1.735 -14.510 4.678 2.048 4.496 4.515
Net Profit/Loss - EUR 1.966 1.965 -2.536 -3.177 -2.322 -15.017 4.151 1.647 3.132 3.769
Employees 3 3 3 3 3 3 1 1 1 1
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate. In the last year of activity, the sales decreased by -14.3%, from 45.532 euro in the year 2022, to 38.912 euro in 2023. The Net Profit increased by 646 euro, from 3.132 euro in 2022, to 3.769 in the last year.

Check the financial reports for the company - Farmacia Nr.30 Srl

Rating financiar

Financial Rating -
Farmacia Nr.30 Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Farmacia Nr.30 Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Farmacia Nr.30 Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Farmacia Nr.30 Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Farmacia Nr.30 Srl - CUI 7645454

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 14.093 13.538 12.735 11.865 11.005 10.687 9.796 8.906 8.282 7.616
Current Assets 21.696 24.974 14.521 11.355 11.097 11.638 10.982 9.489 9.990 8.520
Inventories 12.808 13.709 9.233 9.217 10.368 11.533 10.632 8.672 9.574 7.196
Receivables 392 59 74 64 92 51 63 87 282 76
Cash 8.497 11.206 5.215 2.074 637 54 287 730 135 1.248
Shareholders Funds 34.215 36.466 24.933 21.333 18.620 3.242 7.331 8.816 11.974 15.707
Social Capital 1.062 1.071 1.060 1.042 1.023 1.003 984 962 965 962
Debts 1.574 2.046 2.323 1.886 3.482 19.082 13.446 9.579 6.298 429
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "7500 - 7500"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 8.520 euro in 2023 which includes Inventories of 7.196 euro, Receivables of 76 euro and cash availability of 1.248 euro.
The company's Equity was valued at 15.707 euro, while total Liabilities amounted to 429 euro. Equity increased by 3.769 euro, from 11.974 euro in 2022, to 15.707 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Farmacia Nr.30 Srl

Comments - Farmacia Nr.30 Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.